Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
As OneIUSDF 94 12-1 Month Momentum % is -39.50% as of Aug. 01, 2026. GuruFocus rates IUSDF with a GF Score™ of 94/100 and a GF Value™ of $18.07. The stock has 2 warning signs investors should review. Among 120 Medical Distribution companies, As One ranks better than 61.67% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-08-01), As One's 12-1 Month Momentum % is -39.50%.
The industry rank for As One's 12-1 Month Momentum % or its related term are showing as below:
IUSDF's 12-1 Month Momentum % is ranked better than 61.67% of 120
companies
in the Medical Distribution industry
Industry Median: -14.775
vs IUSDF: -39.50
As One (OTCPK:IUSDF) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
As One 12-1 Month Momentum % Related Terms
IUSDF vs MCK, COR, CAH: 12-1 Month Momentum % Comparison
For the Medical Distribution subindustry, As One's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
As One 12-1 Month Momentum % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, As One's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where As One's 12-1 Month Momentum % falls into.
As One (OTCPK:IUSDF) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a 12-1 Month Momentum % of -39.50% mean?
As One (IUSDF) has a 12-1 Month Momentum % of -39.50% as of Aug. 01, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on As One and its competitors. According to the industry distribution chart, As One ranks #46 out of 120 companies in the Medical Distribution industry, placing it in the top 38.3%.
Is As One's 12-1 Month Momentum % too high?
As One's current 12-1 Month Momentum % is -39.50%. Based on the distribution chart, As One ranks #46 out of 120 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, As One has a GF Score™ of 94/100, reflecting its overall financial health beyond just this single metric.
How does As One's 12-1 Month Momentum % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, As One ranks #46 out of 120 companies for 12-1 Month Momentum %. This puts As One in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Medical Distribution company?
A good 12-1 Month Momentum % depends on the Medical Distribution industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on As One and its competitors. As One's current 12-1 Month Momentum % is -39.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is As One stock overvalued right now?
As One (IUSDF) has a current 12-1 Month Momentum % of -39.50%. The stock's GF Value™ is $18.07, compared to a current price of $14.00 — trading 22.5% below its estimated fair value. The current 12-1 Month Momentum % is -39.50%. As One's overall GF Score™ is 94/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For As One (IUSDF), the current 12-1 Month Momentum % is -39.50% as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is As One (IUSDF) Overvalued in 2026?
Based on GuruFocus' analysis, As One stock appears to be undervalued.
The current stock price of $14.00 is trading 22.5% below its estimated GF Value™ of $18.07.
Key valuation signals for IUSDF:
12-1 Month Momentum %: -39.50%
GF Value™: $18.07 vs. price of $14.00 (22.5% below fair value)
No single metric tells the full story. See the IUSDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
As One Corp is a trading engaged in sale of scientific instruments, industrial instruments, hospital or nursing instruments and approach to specialized fields. The company generates maximum revenue from scientific instrument product line which includes measuring instruments; cultivation, separation, analysis products such as microscopes, glass slides, and tissue culture products; Equipment / storage / conveyance products such as experimental platforms, fume hoods; Vessels or containers which includes storage of samples, reagents; Necessities for experiments including glass or plastic beakers, flask indispensable for experiments, hoses, tubes, joints, plus paper products such as tapes and labels; Equipment for laboratories like timers, packaging machines, tools, office supplies.
94GF Score
Get the complete analysis for IUSDF
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IUSDF has been successfully added to your 
